期刊文献+

复合抗原ESAT-6/CFP-10/Rv3615c ELISPOT辅助诊断活动性肺结核的应用价值 被引量:8

Diagnositc value of ELISPOT by multiple antigens in detection of active pulmonary tuberculosis
下载PDF
导出
摘要 目的:评估结核分枝杆菌复合抗原ESAT-6/CFP-10/Rv3615c在活动性肺结核诊断中的应用价值。方法:选取肺结核病患者78例,非结核性肺部疾病患者27例和健康体检者39例,分别用复合抗原ESAT-6/CFP-10/Rv3615c、ESAT-6肽段库和CFP-10肽段库作为抗原刺激单个核淋巴细胞(PBMCs),采用酶联免疫斑点试验检测斑点形成细胞数,判断肺结核感染情况。结果:复合抗原ESAT-6/CFP-10/Rv3615c、ESAT-6肽段库和CFP-10肽段库检测结核分枝杆菌感染的敏感性依次为87.2%(68/78)、80.8%(63/78)、76.9%(60/78),特异性依次为81.8%(54/66)、84.8%(56/66)、87.9%(58/66)。结论:复合抗原ESAT-6/CFP-10/Rv3615c有较高的敏感性和特异性,对活动性肺结核的辅助诊断有一定的临床应用价值。 Aim: To evaluate the value of mycobacterium tuberculosis composite antigen ESAT-6/CFP-10/Rv3615 c in the diagnosis of active pulmonary tuberculosis. Methods: Seventy-eight patients with pulmonary tuberculosis,27 patients with non-tuberculous lung disease and 39 healthy control were selected. The peripheral blood mononuclear cells( PBMCs)were stimulated with the composite antigen ESAT-6/CFP-10/Rv3615 c,ESAT-6 peptide or CFP-10 peptide. SFCs was detected by ELISPOT to determine the situation of tuberculosis infection. Results: The sensitivities of mycobacterium tuberculosis infection detected by the composite antigen ESAT-6/CFP-10/Rv3615 c,ESAT-6 peptide and CFP-10 peptide were87. 2%( 68/78),80. 8%( 63/78),76. 9%( 60/78),respectively,and the specificities were 81. 8%( 54/66),84. 8%( 56/66) and 87. 9%( 58/66),respectively. Conclusion: The complex antigen ESAT-6/CFP-10/Rv3615 c has high sensitivity and specificity,and is of certain clinical value for the auxiliary diagnosis of active pulmonary tuberculosis.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2017年第5期629-633,共5页 Journal of Zhengzhou University(Medical Sciences)
基金 "十二.五"国家科技重大专项2013ZX10003002-005 国家自然科学基金81271794 河南省卫生厅科技攻关项目201204110
关键词 肺结核 ESAT-6 CFP-10 Rv3615c pulmonary tuberculosis ESAT-6 CFP-10 Rv3615 c
  • 相关文献

参考文献7

二级参考文献64

  • 1吴燕,朱中元,王海波.结核分支杆菌38KD蛋白基因克隆及在大肠杆菌中的表达[J].中国热带医学,2005,5(9):1786-1789. 被引量:5
  • 2中国防痨协会基础专业委员会.结核病诊断实验室检验规程[M].北京:中国教育出版社,2006.13-16.
  • 3WHO. Global tuberculosis control: WHO report 2011. Geneva, World Health Organization 2011:URL: http://www.who.int/tb/publications/ global report/2011/gtbr2011 _full.pdf.
  • 4Zhang SL, Zhao JW, Sun ZQ, Yang EZ, Yan JH, Zhao Q, et al. Develop- ment and evaluation of a novel multiple-antigen ELISA for serodiagno- sis of tubereulosis[J]. Tuberculosis 2009,89:278-284.
  • 5Cole ST, Brosch R, Parkhill J, Gamier T, Chureher C, Harris D, et al. Deciphering the biology of Mycobaeterium tuberculosis from the com- plete genome sequence[J]. Nature 1998,393:537-544.
  • 6Byun EH, Kim WS, Shin AR, Kim JS, Whang J, Won C J, et al. Rv0315, a novel immunostimulatory antigen of Mycobacterium tuber- culosis, activates dendritic cells and drives Thl immune responses[J]. J Mol Med 2012,90:285-298.
  • 7SambrookJ,RussellDW.分子克隆实验指南.黄培堂,等译.,第3版[M].北京:科学出版社.2002:611-616.
  • 8Lin XH, Xu SF, Yang YP, Wu JC, Wang H J, Shen HB, et al. Purifica- tion and characterization of anthranilate synthase component I (TrpE) from Mycobacterium tuberculosis H37Rv[J]. Protein Expr Purif 2009, 64:8-15.
  • 9Kunnath-Velayudhan S, Salamon H, Wang HY, Davidow AL, Molina DM, Huynh VT, et al. Dynamic antibody responses to the Mycobacteri- um tuberculosis proteome[J]. Proc Nad Aead Sci U S A 2010,107: 14703-14708.
  • 10WaUis RS, Pai M, Menzies D, Doherty TM, Walzl G, Perkins MD, et al. Biomarkers and diagnostics for tuberculosis: progress, needs, and trans- lation into practice[J]. Lancet 2010,375:1920-1937.

共引文献568

同被引文献72

引证文献8

二级引证文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部